Singapore markets closed

Lonza Group Ltd (LZAGY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
82.74+0.64 (+0.78%)
As of 9:56AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close82.10
Bid0.00 x 0
Ask0.00 x 0
Day's range82.74 - 83.08
52-week range55.69 - 86.31
Avg. volume50,621
Market cap61.462B
Beta (5Y monthly)0.42
PE ratio (TTM)79.92
EPS (TTM)1.04
Earnings dateN/A
Forward dividend & yield0.33 (0.40%)
Ex-dividend date10 May 2021
1y target estN/A
  • Reuters

    Vaccine business helps Lonza lift 2021 sales outlook

    ZURICH (Reuters) -Swiss contract drugmaker Lonza raised its 2021 outlook on Friday after booming business making ingredients for COVID-19 vaccines and strong growth elsewhere helped it beat analysts' expectations during the first half of the year. "In the prior year we provided an estimate for how much we expected from Moderna sales for 2021...the number is much higher given our ability to increase output at our existing facilities," Chief Financial Officer Rodolfo Savitzky told reporters. Its previous guidance had been for sales growth in the low double-digit range.

  • Zacks

    Lonza Group Ag (LZAGY) Upgraded to Buy: What Does It Mean for the Stock?

    Lonza Group Ag (LZAGY) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.